Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03859609Completed

Comparison of GAP-score With Schwab-score

Role: lead

NCT03521661Completed

Efficacy of Kyphoplasty With a New Intervertebral Expander

Role: lead

NCT03063008Not ApplicableCompleted

Transforaminal Lumbar Interbody Fusion in PEEK Oblique Cages With and Without Titanium Coating

Role: lead

NCT02557113Not ApplicableCompleted

Creation of a Small Cavity Reduces the Rate of Cement Leakage During Vertebral Body Augmentation

Role: lead

All 4 trials loaded